Apriem Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.86M | Sell |
|
|||||
|
2025
Q2 | $4.79M | Sell |
|
|||||
|
2025
Q1 | $7.89M | Sell |
|
|||||
|
2024
Q4 | $10.3M | Sell |
|
|||||
|
2024
Q3 | $16.3M | Sell |
|
|||||
|
2024
Q2 | $17.2M | Sell |
|
|||||
|
2024
Q1 | $19.9M | Sell |
|
|||||
|
2023
Q4 | $20.9M | Sell |
|
|||||
|
2023
Q3 | $20.5M | Sell |
|
|||||
|
2023
Q2 | $18.4M | Sell |
|
|||||
|
2023
Q1 | $21.5M | Sell |
|
|||||
|
2022
Q4 | $22.6M | Sell |
|
|||||
|
2022
Q3 | $22.2M | Buy |
|
|||||
|
2022
Q2 | $19M | Buy |
|
|||||
|
2022
Q1 | $22.4M | Buy |
|
|||||
|
2021
Q4 | $20.1M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $10K | Hold |
|
|||||
|
2016
Q4 | $9K | Sell |
|
|||||
|
2016
Q3 | $18K | Hold |
|
|||||
|
2016
Q2 | $16K | Hold |
|
|||||
|
2016
Q1 | $16K | Hold |
|
|||||
|
2015
Q4 | $24K | Hold |
|
|||||
|
2015
Q3 | $21K | Hold |
|
|||||
|
2015
Q2 | $23K | Buy |
|
|||||
|
2015
Q1 | $11K | Buy |
|